nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP2B6—Ifosfamide—testicular cancer	0.101	0.17	CbGbCtD
Citalopram—CYP2C19—Ifosfamide—testicular cancer	0.0644	0.108	CbGbCtD
Citalopram—CYP2B6—Cisplatin—testicular cancer	0.0493	0.0828	CbGbCtD
Citalopram—CYP2E1—Etoposide—testicular cancer	0.0491	0.0825	CbGbCtD
Citalopram—ABCB1—Dactinomycin—testicular cancer	0.044	0.0739	CbGbCtD
Citalopram—CYP2B6—Doxorubicin—testicular cancer	0.033	0.0555	CbGbCtD
Citalopram—CYP3A4—Ifosfamide—testicular cancer	0.0311	0.0523	CbGbCtD
Citalopram—CYP1A2—Etoposide—testicular cancer	0.0284	0.0477	CbGbCtD
Citalopram—ABCB1—Vinblastine—testicular cancer	0.0276	0.0463	CbGbCtD
Citalopram—CYP2D6—Vinblastine—testicular cancer	0.026	0.0436	CbGbCtD
Citalopram—ABCB1—Cisplatin—testicular cancer	0.0253	0.0425	CbGbCtD
Citalopram—ABCB1—Etoposide—testicular cancer	0.0248	0.0417	CbGbCtD
Citalopram—ABCB1—Doxorubicin—testicular cancer	0.0169	0.0285	CbGbCtD
Citalopram—CYP3A4—Vinblastine—testicular cancer	0.0165	0.0277	CbGbCtD
Citalopram—ABCB1—Methotrexate—testicular cancer	0.0164	0.0276	CbGbCtD
Citalopram—CYP2D6—Doxorubicin—testicular cancer	0.016	0.0268	CbGbCtD
Citalopram—CYP3A4—Etoposide—testicular cancer	0.0149	0.025	CbGbCtD
Citalopram—CYP3A4—Doxorubicin—testicular cancer	0.0102	0.0171	CbGbCtD
Citalopram—Oedema peripheral—Epirubicin—testicular cancer	0.000121	0.0003	CcSEcCtD
Citalopram—Haematuria—Doxorubicin—testicular cancer	0.000121	0.000299	CcSEcCtD
Citalopram—Connective tissue disorder—Epirubicin—testicular cancer	0.000121	0.000299	CcSEcCtD
Citalopram—Urethral disorder—Epirubicin—testicular cancer	0.000121	0.000299	CcSEcCtD
Citalopram—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00012	0.000297	CcSEcCtD
Citalopram—Epistaxis—Doxorubicin—testicular cancer	0.00012	0.000296	CcSEcCtD
Citalopram—Angiopathy—Methotrexate—testicular cancer	0.00012	0.000295	CcSEcCtD
Citalopram—Sinusitis—Doxorubicin—testicular cancer	0.000119	0.000295	CcSEcCtD
Citalopram—Immune system disorder—Methotrexate—testicular cancer	0.000119	0.000294	CcSEcCtD
Citalopram—Visual impairment—Epirubicin—testicular cancer	0.000119	0.000294	CcSEcCtD
Citalopram—Mediastinal disorder—Methotrexate—testicular cancer	0.000119	0.000293	CcSEcCtD
Citalopram—Agranulocytosis—Doxorubicin—testicular cancer	0.000119	0.000293	CcSEcCtD
Citalopram—Chills—Methotrexate—testicular cancer	0.000118	0.000292	CcSEcCtD
Citalopram—Nausea—Ifosfamide—testicular cancer	0.000118	0.00029	CcSEcCtD
Citalopram—Diarrhoea—Cisplatin—testicular cancer	0.000117	0.000288	CcSEcCtD
Citalopram—Erythema multiforme—Epirubicin—testicular cancer	0.000117	0.000288	CcSEcCtD
Citalopram—Alopecia—Methotrexate—testicular cancer	0.000116	0.000288	CcSEcCtD
Citalopram—Bradycardia—Doxorubicin—testicular cancer	0.000116	0.000287	CcSEcCtD
Citalopram—Mental disorder—Methotrexate—testicular cancer	0.000115	0.000285	CcSEcCtD
Citalopram—Eye disorder—Epirubicin—testicular cancer	0.000115	0.000285	CcSEcCtD
Citalopram—Hypersensitivity—Etoposide—testicular cancer	0.000115	0.000285	CcSEcCtD
Citalopram—Tinnitus—Epirubicin—testicular cancer	0.000115	0.000284	CcSEcCtD
Citalopram—Malnutrition—Methotrexate—testicular cancer	0.000115	0.000283	CcSEcCtD
Citalopram—Erythema—Methotrexate—testicular cancer	0.000115	0.000283	CcSEcCtD
Citalopram—Haemoglobin—Doxorubicin—testicular cancer	0.000115	0.000283	CcSEcCtD
Citalopram—Flushing—Epirubicin—testicular cancer	0.000114	0.000283	CcSEcCtD
Citalopram—Cardiac disorder—Epirubicin—testicular cancer	0.000114	0.000283	CcSEcCtD
Citalopram—Rhinitis—Doxorubicin—testicular cancer	0.000114	0.000283	CcSEcCtD
Citalopram—Hepatitis—Doxorubicin—testicular cancer	0.000114	0.000282	CcSEcCtD
Citalopram—Haemorrhage—Doxorubicin—testicular cancer	0.000114	0.000282	CcSEcCtD
Citalopram—Hypoaesthesia—Doxorubicin—testicular cancer	0.000114	0.000281	CcSEcCtD
Citalopram—Pharyngitis—Doxorubicin—testicular cancer	0.000113	0.00028	CcSEcCtD
Citalopram—Urinary tract disorder—Doxorubicin—testicular cancer	0.000113	0.000278	CcSEcCtD
Citalopram—Oedema peripheral—Doxorubicin—testicular cancer	0.000112	0.000278	CcSEcCtD
Citalopram—Dysgeusia—Methotrexate—testicular cancer	0.000112	0.000278	CcSEcCtD
Citalopram—Asthenia—Etoposide—testicular cancer	0.000112	0.000277	CcSEcCtD
Citalopram—Connective tissue disorder—Doxorubicin—testicular cancer	0.000112	0.000277	CcSEcCtD
Citalopram—Angiopathy—Epirubicin—testicular cancer	0.000112	0.000276	CcSEcCtD
Citalopram—Urethral disorder—Doxorubicin—testicular cancer	0.000112	0.000276	CcSEcCtD
Citalopram—Immune system disorder—Epirubicin—testicular cancer	0.000111	0.000275	CcSEcCtD
Citalopram—Mediastinal disorder—Epirubicin—testicular cancer	0.000111	0.000275	CcSEcCtD
Citalopram—Back pain—Methotrexate—testicular cancer	0.000111	0.000274	CcSEcCtD
Citalopram—Chills—Epirubicin—testicular cancer	0.000111	0.000273	CcSEcCtD
Citalopram—Pruritus—Etoposide—testicular cancer	0.000111	0.000273	CcSEcCtD
Citalopram—Arrhythmia—Epirubicin—testicular cancer	0.00011	0.000272	CcSEcCtD
Citalopram—Visual impairment—Doxorubicin—testicular cancer	0.00011	0.000272	CcSEcCtD
Citalopram—Alopecia—Epirubicin—testicular cancer	0.000109	0.000269	CcSEcCtD
Citalopram—Vomiting—Cisplatin—testicular cancer	0.000108	0.000268	CcSEcCtD
Citalopram—Vision blurred—Methotrexate—testicular cancer	0.000108	0.000267	CcSEcCtD
Citalopram—Mental disorder—Epirubicin—testicular cancer	0.000108	0.000267	CcSEcCtD
Citalopram—Erythema multiforme—Doxorubicin—testicular cancer	0.000108	0.000267	CcSEcCtD
Citalopram—Rash—Cisplatin—testicular cancer	0.000108	0.000266	CcSEcCtD
Citalopram—Dermatitis—Cisplatin—testicular cancer	0.000107	0.000266	CcSEcCtD
Citalopram—Malnutrition—Epirubicin—testicular cancer	0.000107	0.000265	CcSEcCtD
Citalopram—Erythema—Epirubicin—testicular cancer	0.000107	0.000265	CcSEcCtD
Citalopram—Diarrhoea—Etoposide—testicular cancer	0.000107	0.000264	CcSEcCtD
Citalopram—Eye disorder—Doxorubicin—testicular cancer	0.000107	0.000263	CcSEcCtD
Citalopram—Ill-defined disorder—Methotrexate—testicular cancer	0.000106	0.000263	CcSEcCtD
Citalopram—Tinnitus—Doxorubicin—testicular cancer	0.000106	0.000263	CcSEcCtD
Citalopram—Anaemia—Methotrexate—testicular cancer	0.000106	0.000262	CcSEcCtD
Citalopram—Flushing—Doxorubicin—testicular cancer	0.000106	0.000262	CcSEcCtD
Citalopram—Cardiac disorder—Doxorubicin—testicular cancer	0.000106	0.000262	CcSEcCtD
Citalopram—Flatulence—Epirubicin—testicular cancer	0.000106	0.000261	CcSEcCtD
Citalopram—Tension—Epirubicin—testicular cancer	0.000105	0.00026	CcSEcCtD
Citalopram—Dysgeusia—Epirubicin—testicular cancer	0.000105	0.00026	CcSEcCtD
Citalopram—Nervousness—Epirubicin—testicular cancer	0.000104	0.000258	CcSEcCtD
Citalopram—Back pain—Epirubicin—testicular cancer	0.000104	0.000257	CcSEcCtD
Citalopram—Angiopathy—Doxorubicin—testicular cancer	0.000103	0.000256	CcSEcCtD
Citalopram—Malaise—Methotrexate—testicular cancer	0.000103	0.000256	CcSEcCtD
Citalopram—Dizziness—Etoposide—testicular cancer	0.000103	0.000255	CcSEcCtD
Citalopram—Muscle spasms—Epirubicin—testicular cancer	0.000103	0.000255	CcSEcCtD
Citalopram—Immune system disorder—Doxorubicin—testicular cancer	0.000103	0.000255	CcSEcCtD
Citalopram—Vertigo—Methotrexate—testicular cancer	0.000103	0.000255	CcSEcCtD
Citalopram—Mediastinal disorder—Doxorubicin—testicular cancer	0.000103	0.000254	CcSEcCtD
Citalopram—Leukopenia—Methotrexate—testicular cancer	0.000103	0.000254	CcSEcCtD
Citalopram—Chills—Doxorubicin—testicular cancer	0.000102	0.000253	CcSEcCtD
Citalopram—Arrhythmia—Doxorubicin—testicular cancer	0.000102	0.000252	CcSEcCtD
Citalopram—Nausea—Cisplatin—testicular cancer	0.000101	0.00025	CcSEcCtD
Citalopram—Vision blurred—Epirubicin—testicular cancer	0.000101	0.00025	CcSEcCtD
Citalopram—Alopecia—Doxorubicin—testicular cancer	0.000101	0.000249	CcSEcCtD
Citalopram—Cough—Methotrexate—testicular cancer	0.0001	0.000247	CcSEcCtD
Citalopram—Mental disorder—Doxorubicin—testicular cancer	9.99e-05	0.000247	CcSEcCtD
Citalopram—Ill-defined disorder—Epirubicin—testicular cancer	9.96e-05	0.000246	CcSEcCtD
Citalopram—Convulsion—Methotrexate—testicular cancer	9.94e-05	0.000246	CcSEcCtD
Citalopram—Vomiting—Etoposide—testicular cancer	9.94e-05	0.000246	CcSEcCtD
Citalopram—Malnutrition—Doxorubicin—testicular cancer	9.93e-05	0.000245	CcSEcCtD
Citalopram—Erythema—Doxorubicin—testicular cancer	9.93e-05	0.000245	CcSEcCtD
Citalopram—Anaemia—Epirubicin—testicular cancer	9.92e-05	0.000245	CcSEcCtD
Citalopram—Agitation—Epirubicin—testicular cancer	9.86e-05	0.000244	CcSEcCtD
Citalopram—Rash—Etoposide—testicular cancer	9.85e-05	0.000243	CcSEcCtD
Citalopram—Dermatitis—Etoposide—testicular cancer	9.84e-05	0.000243	CcSEcCtD
Citalopram—Headache—Etoposide—testicular cancer	9.79e-05	0.000242	CcSEcCtD
Citalopram—Flatulence—Doxorubicin—testicular cancer	9.79e-05	0.000242	CcSEcCtD
Citalopram—Chest pain—Methotrexate—testicular cancer	9.76e-05	0.000241	CcSEcCtD
Citalopram—Myalgia—Methotrexate—testicular cancer	9.76e-05	0.000241	CcSEcCtD
Citalopram—Arthralgia—Methotrexate—testicular cancer	9.76e-05	0.000241	CcSEcCtD
Citalopram—Tension—Doxorubicin—testicular cancer	9.74e-05	0.000241	CcSEcCtD
Citalopram—Dysgeusia—Doxorubicin—testicular cancer	9.72e-05	0.00024	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	9.7e-05	0.00024	CcSEcCtD
Citalopram—Malaise—Epirubicin—testicular cancer	9.68e-05	0.000239	CcSEcCtD
Citalopram—Discomfort—Methotrexate—testicular cancer	9.65e-05	0.000238	CcSEcCtD
Citalopram—Nervousness—Doxorubicin—testicular cancer	9.64e-05	0.000238	CcSEcCtD
Citalopram—Vertigo—Epirubicin—testicular cancer	9.64e-05	0.000238	CcSEcCtD
Citalopram—Syncope—Epirubicin—testicular cancer	9.62e-05	0.000238	CcSEcCtD
Citalopram—Leukopenia—Epirubicin—testicular cancer	9.61e-05	0.000237	CcSEcCtD
Citalopram—Back pain—Doxorubicin—testicular cancer	9.61e-05	0.000237	CcSEcCtD
Citalopram—Muscle spasms—Doxorubicin—testicular cancer	9.55e-05	0.000236	CcSEcCtD
Citalopram—Palpitations—Epirubicin—testicular cancer	9.48e-05	0.000234	CcSEcCtD
Citalopram—Confusional state—Methotrexate—testicular cancer	9.44e-05	0.000233	CcSEcCtD
Citalopram—Loss of consciousness—Epirubicin—testicular cancer	9.43e-05	0.000233	CcSEcCtD
Citalopram—Cough—Epirubicin—testicular cancer	9.37e-05	0.000231	CcSEcCtD
Citalopram—Anaphylactic shock—Methotrexate—testicular cancer	9.36e-05	0.000231	CcSEcCtD
Citalopram—Vision blurred—Doxorubicin—testicular cancer	9.36e-05	0.000231	CcSEcCtD
Citalopram—Convulsion—Epirubicin—testicular cancer	9.3e-05	0.00023	CcSEcCtD
Citalopram—Infection—Methotrexate—testicular cancer	9.3e-05	0.00023	CcSEcCtD
Citalopram—Nausea—Etoposide—testicular cancer	9.28e-05	0.000229	CcSEcCtD
Citalopram—Hypertension—Epirubicin—testicular cancer	9.27e-05	0.000229	CcSEcCtD
Citalopram—Ill-defined disorder—Doxorubicin—testicular cancer	9.21e-05	0.000228	CcSEcCtD
Citalopram—Nervous system disorder—Methotrexate—testicular cancer	9.18e-05	0.000227	CcSEcCtD
Citalopram—Anaemia—Doxorubicin—testicular cancer	9.18e-05	0.000227	CcSEcCtD
Citalopram—Thrombocytopenia—Methotrexate—testicular cancer	9.16e-05	0.000226	CcSEcCtD
Citalopram—Arthralgia—Epirubicin—testicular cancer	9.14e-05	0.000226	CcSEcCtD
Citalopram—Chest pain—Epirubicin—testicular cancer	9.14e-05	0.000226	CcSEcCtD
Citalopram—Myalgia—Epirubicin—testicular cancer	9.14e-05	0.000226	CcSEcCtD
Citalopram—Agitation—Doxorubicin—testicular cancer	9.13e-05	0.000226	CcSEcCtD
Citalopram—Anxiety—Epirubicin—testicular cancer	9.11e-05	0.000225	CcSEcCtD
Citalopram—Skin disorder—Methotrexate—testicular cancer	9.09e-05	0.000225	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	9.07e-05	0.000224	CcSEcCtD
Citalopram—Hyperhidrosis—Methotrexate—testicular cancer	9.05e-05	0.000224	CcSEcCtD
Citalopram—Discomfort—Epirubicin—testicular cancer	9.03e-05	0.000223	CcSEcCtD
Citalopram—Malaise—Doxorubicin—testicular cancer	8.96e-05	0.000221	CcSEcCtD
Citalopram—Dry mouth—Epirubicin—testicular cancer	8.94e-05	0.000221	CcSEcCtD
Citalopram—Vertigo—Doxorubicin—testicular cancer	8.92e-05	0.00022	CcSEcCtD
Citalopram—Anorexia—Methotrexate—testicular cancer	8.92e-05	0.00022	CcSEcCtD
Citalopram—Syncope—Doxorubicin—testicular cancer	8.91e-05	0.00022	CcSEcCtD
Citalopram—Leukopenia—Doxorubicin—testicular cancer	8.89e-05	0.00022	CcSEcCtD
Citalopram—Confusional state—Epirubicin—testicular cancer	8.83e-05	0.000218	CcSEcCtD
Citalopram—Palpitations—Doxorubicin—testicular cancer	8.78e-05	0.000217	CcSEcCtD
Citalopram—Anaphylactic shock—Epirubicin—testicular cancer	8.76e-05	0.000216	CcSEcCtD
Citalopram—Oedema—Epirubicin—testicular cancer	8.76e-05	0.000216	CcSEcCtD
Citalopram—Hypotension—Methotrexate—testicular cancer	8.75e-05	0.000216	CcSEcCtD
Citalopram—Loss of consciousness—Doxorubicin—testicular cancer	8.73e-05	0.000216	CcSEcCtD
Citalopram—Infection—Epirubicin—testicular cancer	8.7e-05	0.000215	CcSEcCtD
Citalopram—Cough—Doxorubicin—testicular cancer	8.67e-05	0.000214	CcSEcCtD
Citalopram—Shock—Epirubicin—testicular cancer	8.62e-05	0.000213	CcSEcCtD
Citalopram—Convulsion—Doxorubicin—testicular cancer	8.6e-05	0.000213	CcSEcCtD
Citalopram—Nervous system disorder—Epirubicin—testicular cancer	8.59e-05	0.000212	CcSEcCtD
Citalopram—Thrombocytopenia—Epirubicin—testicular cancer	8.58e-05	0.000212	CcSEcCtD
Citalopram—Hypertension—Doxorubicin—testicular cancer	8.57e-05	0.000212	CcSEcCtD
Citalopram—Tachycardia—Epirubicin—testicular cancer	8.55e-05	0.000211	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.53e-05	0.000211	CcSEcCtD
Citalopram—Skin disorder—Epirubicin—testicular cancer	8.51e-05	0.00021	CcSEcCtD
Citalopram—Hyperhidrosis—Epirubicin—testicular cancer	8.47e-05	0.000209	CcSEcCtD
Citalopram—Insomnia—Methotrexate—testicular cancer	8.47e-05	0.000209	CcSEcCtD
Citalopram—Arthralgia—Doxorubicin—testicular cancer	8.45e-05	0.000209	CcSEcCtD
Citalopram—Myalgia—Doxorubicin—testicular cancer	8.45e-05	0.000209	CcSEcCtD
Citalopram—Chest pain—Doxorubicin—testicular cancer	8.45e-05	0.000209	CcSEcCtD
Citalopram—Anxiety—Doxorubicin—testicular cancer	8.43e-05	0.000208	CcSEcCtD
Citalopram—Paraesthesia—Methotrexate—testicular cancer	8.4e-05	0.000208	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	8.4e-05	0.000207	CcSEcCtD
Citalopram—Discomfort—Doxorubicin—testicular cancer	8.35e-05	0.000206	CcSEcCtD
Citalopram—Anorexia—Epirubicin—testicular cancer	8.35e-05	0.000206	CcSEcCtD
Citalopram—Dyspnoea—Methotrexate—testicular cancer	8.34e-05	0.000206	CcSEcCtD
Citalopram—Somnolence—Methotrexate—testicular cancer	8.32e-05	0.000206	CcSEcCtD
Citalopram—Dry mouth—Doxorubicin—testicular cancer	8.27e-05	0.000204	CcSEcCtD
Citalopram—Dyspepsia—Methotrexate—testicular cancer	8.24e-05	0.000204	CcSEcCtD
Citalopram—Hypotension—Epirubicin—testicular cancer	8.18e-05	0.000202	CcSEcCtD
Citalopram—Confusional state—Doxorubicin—testicular cancer	8.17e-05	0.000202	CcSEcCtD
Citalopram—Decreased appetite—Methotrexate—testicular cancer	8.14e-05	0.000201	CcSEcCtD
Citalopram—Anaphylactic shock—Doxorubicin—testicular cancer	8.1e-05	0.0002	CcSEcCtD
Citalopram—Oedema—Doxorubicin—testicular cancer	8.1e-05	0.0002	CcSEcCtD
Citalopram—Gastrointestinal disorder—Methotrexate—testicular cancer	8.08e-05	0.0002	CcSEcCtD
Citalopram—Fatigue—Methotrexate—testicular cancer	8.07e-05	0.000199	CcSEcCtD
Citalopram—Infection—Doxorubicin—testicular cancer	8.05e-05	0.000199	CcSEcCtD
Citalopram—Pain—Methotrexate—testicular cancer	8e-05	0.000198	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.98e-05	0.000197	CcSEcCtD
Citalopram—Shock—Doxorubicin—testicular cancer	7.97e-05	0.000197	CcSEcCtD
Citalopram—Nervous system disorder—Doxorubicin—testicular cancer	7.95e-05	0.000196	CcSEcCtD
Citalopram—Thrombocytopenia—Doxorubicin—testicular cancer	7.94e-05	0.000196	CcSEcCtD
Citalopram—Insomnia—Epirubicin—testicular cancer	7.92e-05	0.000196	CcSEcCtD
Citalopram—Tachycardia—Doxorubicin—testicular cancer	7.91e-05	0.000195	CcSEcCtD
Citalopram—Skin disorder—Doxorubicin—testicular cancer	7.87e-05	0.000195	CcSEcCtD
Citalopram—Paraesthesia—Epirubicin—testicular cancer	7.87e-05	0.000194	CcSEcCtD
Citalopram—Hyperhidrosis—Doxorubicin—testicular cancer	7.83e-05	0.000194	CcSEcCtD
Citalopram—Dyspnoea—Epirubicin—testicular cancer	7.81e-05	0.000193	CcSEcCtD
Citalopram—Somnolence—Epirubicin—testicular cancer	7.79e-05	0.000192	CcSEcCtD
Citalopram—Anorexia—Doxorubicin—testicular cancer	7.73e-05	0.000191	CcSEcCtD
Citalopram—Feeling abnormal—Methotrexate—testicular cancer	7.71e-05	0.000191	CcSEcCtD
Citalopram—Dyspepsia—Epirubicin—testicular cancer	7.71e-05	0.000191	CcSEcCtD
Citalopram—Gastrointestinal pain—Methotrexate—testicular cancer	7.65e-05	0.000189	CcSEcCtD
Citalopram—Decreased appetite—Epirubicin—testicular cancer	7.61e-05	0.000188	CcSEcCtD
Citalopram—Hypotension—Doxorubicin—testicular cancer	7.57e-05	0.000187	CcSEcCtD
Citalopram—Gastrointestinal disorder—Epirubicin—testicular cancer	7.56e-05	0.000187	CcSEcCtD
Citalopram—Fatigue—Epirubicin—testicular cancer	7.55e-05	0.000187	CcSEcCtD
Citalopram—Pain—Epirubicin—testicular cancer	7.49e-05	0.000185	CcSEcCtD
Citalopram—Constipation—Epirubicin—testicular cancer	7.49e-05	0.000185	CcSEcCtD
Citalopram—Urticaria—Methotrexate—testicular cancer	7.44e-05	0.000184	CcSEcCtD
Citalopram—Body temperature increased—Methotrexate—testicular cancer	7.4e-05	0.000183	CcSEcCtD
Citalopram—Abdominal pain—Methotrexate—testicular cancer	7.4e-05	0.000183	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.38e-05	0.000182	CcSEcCtD
Citalopram—Insomnia—Doxorubicin—testicular cancer	7.33e-05	0.000181	CcSEcCtD
Citalopram—Paraesthesia—Doxorubicin—testicular cancer	7.28e-05	0.00018	CcSEcCtD
Citalopram—Dyspnoea—Doxorubicin—testicular cancer	7.23e-05	0.000179	CcSEcCtD
Citalopram—Feeling abnormal—Epirubicin—testicular cancer	7.22e-05	0.000178	CcSEcCtD
Citalopram—Somnolence—Doxorubicin—testicular cancer	7.2e-05	0.000178	CcSEcCtD
Citalopram—Gastrointestinal pain—Epirubicin—testicular cancer	7.16e-05	0.000177	CcSEcCtD
Citalopram—Dyspepsia—Doxorubicin—testicular cancer	7.13e-05	0.000176	CcSEcCtD
Citalopram—Decreased appetite—Doxorubicin—testicular cancer	7.05e-05	0.000174	CcSEcCtD
Citalopram—Gastrointestinal disorder—Doxorubicin—testicular cancer	7e-05	0.000173	CcSEcCtD
Citalopram—Fatigue—Doxorubicin—testicular cancer	6.99e-05	0.000173	CcSEcCtD
Citalopram—Urticaria—Epirubicin—testicular cancer	6.96e-05	0.000172	CcSEcCtD
Citalopram—Pain—Doxorubicin—testicular cancer	6.93e-05	0.000171	CcSEcCtD
Citalopram—Constipation—Doxorubicin—testicular cancer	6.93e-05	0.000171	CcSEcCtD
Citalopram—Abdominal pain—Epirubicin—testicular cancer	6.92e-05	0.000171	CcSEcCtD
Citalopram—Body temperature increased—Epirubicin—testicular cancer	6.92e-05	0.000171	CcSEcCtD
Citalopram—Hypersensitivity—Methotrexate—testicular cancer	6.9e-05	0.00017	CcSEcCtD
Citalopram—Asthenia—Methotrexate—testicular cancer	6.72e-05	0.000166	CcSEcCtD
Citalopram—Feeling abnormal—Doxorubicin—testicular cancer	6.68e-05	0.000165	CcSEcCtD
Citalopram—Gastrointestinal pain—Doxorubicin—testicular cancer	6.63e-05	0.000164	CcSEcCtD
Citalopram—Pruritus—Methotrexate—testicular cancer	6.62e-05	0.000164	CcSEcCtD
Citalopram—Hypersensitivity—Epirubicin—testicular cancer	6.45e-05	0.000159	CcSEcCtD
Citalopram—Urticaria—Doxorubicin—testicular cancer	6.44e-05	0.000159	CcSEcCtD
Citalopram—Abdominal pain—Doxorubicin—testicular cancer	6.41e-05	0.000158	CcSEcCtD
Citalopram—Body temperature increased—Doxorubicin—testicular cancer	6.41e-05	0.000158	CcSEcCtD
Citalopram—Diarrhoea—Methotrexate—testicular cancer	6.4e-05	0.000158	CcSEcCtD
Citalopram—Asthenia—Epirubicin—testicular cancer	6.28e-05	0.000155	CcSEcCtD
Citalopram—Pruritus—Epirubicin—testicular cancer	6.2e-05	0.000153	CcSEcCtD
Citalopram—Dizziness—Methotrexate—testicular cancer	6.19e-05	0.000153	CcSEcCtD
Citalopram—Diarrhoea—Epirubicin—testicular cancer	5.99e-05	0.000148	CcSEcCtD
Citalopram—Hypersensitivity—Doxorubicin—testicular cancer	5.97e-05	0.000148	CcSEcCtD
Citalopram—Vomiting—Methotrexate—testicular cancer	5.95e-05	0.000147	CcSEcCtD
Citalopram—Rash—Methotrexate—testicular cancer	5.9e-05	0.000146	CcSEcCtD
Citalopram—Dermatitis—Methotrexate—testicular cancer	5.9e-05	0.000146	CcSEcCtD
Citalopram—Headache—Methotrexate—testicular cancer	5.86e-05	0.000145	CcSEcCtD
Citalopram—Asthenia—Doxorubicin—testicular cancer	5.81e-05	0.000144	CcSEcCtD
Citalopram—Dizziness—Epirubicin—testicular cancer	5.79e-05	0.000143	CcSEcCtD
Citalopram—Pruritus—Doxorubicin—testicular cancer	5.73e-05	0.000142	CcSEcCtD
Citalopram—Vomiting—Epirubicin—testicular cancer	5.57e-05	0.000138	CcSEcCtD
Citalopram—Nausea—Methotrexate—testicular cancer	5.56e-05	0.000137	CcSEcCtD
Citalopram—Diarrhoea—Doxorubicin—testicular cancer	5.55e-05	0.000137	CcSEcCtD
Citalopram—Rash—Epirubicin—testicular cancer	5.52e-05	0.000136	CcSEcCtD
Citalopram—Dermatitis—Epirubicin—testicular cancer	5.52e-05	0.000136	CcSEcCtD
Citalopram—Headache—Epirubicin—testicular cancer	5.49e-05	0.000136	CcSEcCtD
Citalopram—Dizziness—Doxorubicin—testicular cancer	5.36e-05	0.000132	CcSEcCtD
Citalopram—Nausea—Epirubicin—testicular cancer	5.2e-05	0.000129	CcSEcCtD
Citalopram—Vomiting—Doxorubicin—testicular cancer	5.15e-05	0.000127	CcSEcCtD
Citalopram—Rash—Doxorubicin—testicular cancer	5.11e-05	0.000126	CcSEcCtD
Citalopram—Dermatitis—Doxorubicin—testicular cancer	5.11e-05	0.000126	CcSEcCtD
Citalopram—Headache—Doxorubicin—testicular cancer	5.08e-05	0.000125	CcSEcCtD
Citalopram—Nausea—Doxorubicin—testicular cancer	4.81e-05	0.000119	CcSEcCtD
